NeuroBooster Array: A Genome-Wide Genotyping Platform to Study Neurological Disorders Across Diverse Populations

Sara Bandres-Ciga1, Faraz Faghri1,2, Elisa Majounie3

  • 1Center for Alzheimer's and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.

Summary

The new Illumina NeuroBooster array (NBA) enhances genetic studies for neurological disorders, improving diversity and global research inclusivity. This cost-effective platform screens for thousands of neuro-specific variants across diverse populations.